OptimizeRx Corporation (OPRX) Return on equity 2016–2025
OptimizeRx Corporation (OPRX) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
4.0%FY2025 · since FY2016: -19.7% → 4.0%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 4.0% | +21.2 pp |
| FY2024 | -17.2% | -3.3 pp |
| FY2023 | -13.9% | -4.8 pp |
| FY2022 | -9.1% | -9.4 pp |
| FY2021 | 0.3% | +4.7 pp |
| FY2020 | -4.4% | +2.6 pp |
| FY2019 | -7.0% | -8.2 pp |
| FY2018 | 1.2% | +35.1 pp |
| FY2017 | -33.8% | -14.1 pp |
| FY2016 | -19.7% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice